I don't disagree but you're also forgetting the broader market picture. Other biotechs and small caps are trading for negative EV. We are in a deep bear market outside of the mega-cap names hiding that reality from the popular indexes. There is no appetite for companies with increasing losses and uncertain prospects when you can earn 5.5% on ultra short duration money market funds. Eventually the rate hiking cycle will be over and market sentiment will turn. That should allow companies like RVNC to trade at much better multiples.
Looking back at the FUD attack from now proven liar CosmeticMD, it definitely is clear that many will fight tooth and nail to resist Daxxify even though it is the superior product. Of course I was not surprised by the FUD, but discovering who CosmeticMD actually is and seeing how somebody like that could be behind such a vicious smear campaign against RVNC was a bit eye opening. We also know now that this private TBCD FB group exists where FUD is spreading unchecked. There will be more upcoming waves of disinformation on this board most certainly.
RVNC has a difficult battle ahead for sure and management needs to be more focused and not make assumptions like Dew has done.
Market Data 
Markets 
AI
